Life After Chevron: User Fee Cycle May Help US FDA In Era Of Uncertainty

uncertainty
The FDA and Congress can use the user fee reauthorizations to deal with regulatory uncertainty. • Source: Shutterstock

More from Legal & IP

More from Pink Sheet